To date, the most widely used biomarker in the clinic for GI cancer is carcinoembryonic antigen (CEA), a protein found in CRC and CCA patients that plays an important role in cell adhesion and intracellular signaling [280]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.